Top news of the week: 08.09.2020.

Biotechnology, Clinical trial, Vaccine, Hoechst AG, Press release, GlaxoSmithKline

Healthcare

On Sep 3, 2020
@BiotechSweden shared
Biotech leaders call for Covid-19 data transparency, FDA independence #BioTech #ui via https://t.co/2sI0UxJbpn https://t.co/kKbPIVYwyf
Open

Prominent biotech leaders release Covid-19 guidelines calling for FDA independence, data transparency

Prominent biotech leaders release Covid-19 guidelines calling for FDA independence, data transparency

The guidance was laid out in a letter signed by leaders of eight biotech companies — including Alnylam and Alkermes — and BIO's president.

On Sep 2, 2020
@adamfeuerstein shared
RT @statnews: BREAKING: Experimental drug for ALS, dreamed up in a dorm room, offers patients glimmer of hope https://t.co/YuRRoZ4ZdK
Open

Experimental drug for ALS, dreamed up in a dorm room, offers patients glimmer of hope

Experimental drug for ALS, dreamed up in a dorm room, offers patients glimmer of hope

Patients who took the medication retained a higher level of certain motor functions than those given a placebo, researchers say.

On Sep 2, 2020
@BiotechSweden shared
Dr. Fauci was not the first CEO and other false claims about biotech company Moderna #BioTech via https://t.co/2sI0UxJbpn https://t.co/m5VU6nfeKb
Open

Fact check: Dr. Fauci was not the first CEO and other false claims about biotech company Moderna

Fact check: Dr. Fauci was not the first CEO and other false claims about biotech company Moderna

Tens of thousands of users are sharing a series of claims that link Dr. Anthony Fauci, Bill Gates, George Soros and Jeffrey Epstein to Moderna, one of the leading contenders in the race to ...

On Sep 7, 2020
@BiotechSweden shared
RT @teepee_vrm: Biotech, #cybersecurity, yellow pages companies join pandemic rush to nasdaq https://t.co/yaflVjVYsq https://t.co/pl4P18CPVc
Open

Biotech, cybersecurity, Yellow Pages companies join pandemic rush to Nasdaq

Biotech, cybersecurity, Yellow Pages companies join pandemic rush to Nasdaq

Three Dallas-Fort Worth companies are joining a pandemic rush to the public trading markets, including a promising biotech startup spawned from research at...

On Sep 4, 2020
@BiotechSweden shared
China biotech InxMed bags $19M Series A+ to develop PhI FAK inhibitor #BioTech via https://t.co/2sI0UxJbpn https://t.co/YQ0IuxWHqc
Open

China biotech InxMed bags $19M Series A+ to develop PhI FAK inhibitor

China biotech InxMed bags $19M Series A+ to develop PhI FAK inhibitor

Nearly a year after Nanjing, China-based InxMed bagged its first-ever IND approval, the company has raked in ¥130 million (about $19 million) in a Series A+ to develop its focal adhesion ...

On Sep 2, 2020
@BiotechSweden shared
3 Pharma Stocks That Are COVID-19 Resistant #BioTech via https://t.co/2sI0UxJbpn https://t.co/0XmKMX2Jhr
Open

3 Pharma Stocks That Are COVID-19 Resistant

3 Pharma Stocks That Are COVID-19 Resistant

The race for a novel coronavirus vaccine has lit a fuse under biotech and pharmaceutical companies. 2020 will surely be remembered as the year of COVID-19 and an unprecedented...

On Sep 1, 2020
@Dominic_Tyer shared
NHS telemedicine ambitions approach a pivotal point https://t.co/syQ8rxmFtc
Open

NHS telemedicine ambitions approach a pivotal point

NHS telemedicine ambitions approach a pivotal point

The UK government has said it is vital to adopt telemedicine across the NHS in response to COVID-19 – but is the health service ready to fully embrace this digital tech?

On Sep 7, 2020
@matthewherper shared
Pharma drew a line over Covid-19 vaccine readiness because someone had to, ⁦@pharmalot⁩ writes. https://t.co/JJ8G8KKVB8
Open

Pharma drew a line in the sand over Covid-19 vaccine readiness — because someone had to

Pharma drew a line in the sand over Covid-19 vaccine readiness — because someone had to

Trump may want a Covid-19 vaccine to ship before the election, but drug makers don't appear ready to cooperate — at least, not on his terms.